Nest Genomics

Nest Genomics is a company founded in 2020 headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Nest Genomics develops a lab-agnostic, comprehensive software platform that enables healthcare organizations to launch and implement large-scale genomic programs. The platform supports risk assessment, patient education, test ordering, clinical decision support, and patient management across the continuum of care.